In vitro-induced resistance to the deoxycytidine analogues cytarabine (AraC) and 5-aza-2′-deoxycytidine (DAC) in a rat model for acute myeloid leukemia is mediated by mutations in the deoxycytidine kinase (dck) gene-Reference-Cited by-同舟云学术

In vitro-induced resistance to the deoxycytidine analogues cytarabine (AraC) and 5-aza-2′-deoxycytidine (DAC) in a rat model for acute myeloid leukemia is mediated by mutations in the deoxycytidine kinase (dck) gene

Published:1995-07 Issue:1 Volume:71 Page:41-47
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Stegmann A. P. A.,Honders M. W.,Hagemeijer A.,Hoebee B.,Willemze R.,Landegent J. E.

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF01696231.pdf

Reference30 articles.

1. Arkesteijn GJA, Martens ACM, Jonker RR, Hagemeijer A, Hagenbeek A (1987) Bivariate flow karyotyping of acute myelocytic leukemia in the BNML rat model. Cytometry 8:618–624

2. Bhalla K, Nayak R, Grant S (1984) Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-β-d-arabinofuranosylcytosine. Cancer Res 44:5029–5037

3. Brien SJ O', Peters J, Searle A, Womack J, Marshall-Graves J (1993) Report of the committee on comparative gene mapping. Genome Priority Rep 1:758–809

4. Datta NS, Shewach DS, Hurley MC, Mitchell BS, Fox IF (1989) Human T-lymphoblast deoxycytidine kinase: purification and properties. Biochemistry 28:114–123

5. Debusscher L, Marie JP, Dochin P, Blanc GM, Arrigo C, Zittoun R, Stryckmans P (1989) Phase I-III trial of 5-aza-2′-deoxycytidine in adult patients with acute leukemia. In: Momparler RL, De Vos D (eds) Proceedings of a workshop: 5-aza-2′-deoxycytidine, preclinical and clinical studies. PCH Publications, Haarlem

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomedicine and epigenome: Possible health risks, benefits, and future perspectives;Cancer Epigenetics and Nanomedicine;2024

2. CD45 inhibition in myeloid leukaemia cells sensitizes cellular responsiveness to chemotherapy;Annals of Hematology;2023-11-02

3. TGFBR3 promoter methylation is a prognostic indicator and not responding to decitabine treatment in hepatocellular carcinoma;Egyptian Journal of Chemistry;2023-04-26

4. The expression and activity of thymidine kinase 1 and deoxycytidine kinase are modulated by hydrogen peroxide and nucleoside analogs;Nucleosides, Nucleotides & Nucleic Acids;2020-03-19

5. The hENT1 and DCK genes underlie the decitabine response in patients with myelodysplastic syndrome;Leukemia Research;2015-02